This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: The University of North Carolina at Chapel Hill, Biotech Research Laboratories, Biotech Research Labs, Inc.. Active years: 1997-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,329 
1 out of 8 
1 out of 2 Years Active: 1997-2001
Title: A Spotlight on Inventor Louis Mark Cosentino
Introduction
Louis Mark Cosentino, a notable inventor based in Springfield, Virginia, has made significant contributions to the field of medicinal chemistry. With a total of three patents to his name, Cosentino is recognized for his innovative work in developing compounds that demonstrate potent anti-HIV activity.
Latest Patents
Among his latest patents are the revolutionary acylated betulin and dihydrobetulin derivatives. These compounds have been found to exhibit significant anti-HIV properties, showcasing their potential in therapeutic applications. The detailed formulations include various acyl groups substituted at the C3-hydroxy group of betulinic acid and dihydrobetulinic acid. The derivatives encompass a range of molecular structures, including mono- or dicarboxylacyl groups with carbon chains ranging from 2 to 20. Such developments have the potential to pave the way for novel treatments in antiviral therapies.
In addition to this, Cosentino has patented betulinic acid and dihydrobetulinic acid acyl derivatives, further emphasizing their potent anti-HIV activity. The innovations detailed in these patents highlight the intricate chemistry behind the formulations, which may lead to effective treatments against HIV.
Career Highlights
Throughout his career, Louis Cosentino has been associated with prestigious institutions. He has worked at the University of North Carolina at Chapel Hill, where he contributed to the advancement of research in medicinal compounds. Additionally, his time at Biotech Research Labs, Inc. allowed him to collaborate with other brilliant minds in the field of biotechnology, enhancing his research endeavors.
Collaborations
Cosentino has collaborated with esteemed colleagues, including Kuo-Hsiung Lee and Yoshiki Kashiwada. These partnerships have been instrumental in driving forward the research on potential anti-HIV compounds, highlighting the importance of collaboration in scientific innovation.
Conclusion
Louis Mark Cosentino continues to be a pivotal figure in the realm of medicinal chemistry. His innovative patents and collaborations demonstrate his commitment to developing compounds that can significantly impact health, particularly in the fight against HIV. As research advances, the implications of his work may lead to groundbreaking therapies, showcasing the vital role of inventors in the realm of science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile